NBY
AMEX · Pharmaceuticals
Novabay Pharmaceuticals Inc
$1.04
+0.20 (+23.81%)
Open$0.85
Previous Close$0.84
Day High$1.13
Day Low$0.85
52W High$99.75
52W Low—
Volume—
Avg Volume224.7K
Market Cap51.92M
P/E Ratio—
EPS$-4.09
SectorPharmaceuticals
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 178.02M | 169.35M | 19.57M |
| Net Income | -131,459,511 | -112,550,951 | 4.44M |
| Profit Margin | -73.9% | -70.2% | 22.7% |
| EBITDA | -130,167,723 | -117,636,355 | 7.02M |
| Free Cash Flow | — | — | 4.00M |
| Rev Growth | +5.1% | +5.1% | -0.9% |
| Debt/Equity | 0.34 | 0.34 | 0.49 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,170.14 | +0.45% | 40.7 | 1.09T |
| JNJ | Johnson & Johnson | $269.19 | -0.10% | 30.6 | 644.12B |
| MRK | Merck & Co. Inc. | $150.91 | +0.94% | 114.0 | 361.66B |
| PFE | Pfizer Inc. | $27.93 | +0.68% | 36.4 | 157.54B |
| BMY | Bristol-Myers Squibb Co | $62.25 | -0.59% | 13.9 | 128.81B |
| ZTS | Zoetis Inc | $72.86 | +2.15% | 11.5 | 30.15B |